Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 28.13 Delayed Data As of Aug 11 |  -0.40 / -1.40%Today’s Change | 17.67 Today|||52-Week Range 41.49 | +1.63% Year-to-Date |
Latest IOVA News | Press Releases
No recent news for Iovance Biotherapeutics Inc.
Today’s Trading
| Previous close | 28.53 |
| Today’s open | 29.12 |
| Day’s range | 27.59 - 29.19 |
| Volume | 55,199 |
| Average volume (3 months) | 1,855,668 |
| Market cap | $4.3B |
Data as of 3:59pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | -25.07% |
| Earnings growth (this year) | -26.83% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | -1.07 | -1.42% |
| ARWRArrowhead Pharmaceut... | +0.16 | +0.40% |
| MORMorphoSys AG | +1.25 | +4.06% |
| BLUEbluebird bio Inc | -3.28 | -4.99% |
Data as of 4:00pm ET, 08/11/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$197.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
